Consistent with the RT-PCT and Western Blot analysis of HH signal cascade components, the stimulating effect of SHH was detectable solely in the CD133+ glioma population, the proliferation index in CD133− cells remained unaffected (Fig. 2C). The gene discussed is PROM1; the disease is central nervous system cancer.